News Daily News FDA Panel Talks Labeling, Urges Cooperation for Paclitaxel Mortality Signal in PAD L.A. McKeown June 20, 2019
News Daily News FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting L.A. McKeown June 10, 2019
News Conference News EuroPCR 2019 EFFPAC: Novel Paclitaxel DCB for PAD Demonstrates Efficacy With No Mortality Signal L.A. McKeown May 23, 2019
News Daily News ‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA L.A. McKeown February 20, 2019
News Daily News Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons L.A. McKeown February 19, 2019
News Daily News IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease L.A. McKeown January 25, 2019
News Daily News Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies L.A. McKeown January 23, 2019
News Daily News Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD L.A. McKeown December 17, 2018
News Daily News CV Devices in the Fast Lane: FDA’s Approval Often Rests on Early Evidence Caitlin E. Cox September 05, 2018
News Daily News REAL PTX: Head-to-Head DCB, DES Data in PAD Show Trend Favoring Stenting at 36 Months L.A. McKeown February 11, 2018